Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging through his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr. Attariwala has worked closely with the breath testing technology leaders and has utilized his educational training and background in biomedical engineering to formulate product design and patent applications for Cannabix.  Dr.  Attariwala also has several other medical device patents under developments in the field of nuclear medicine. Dr. Attariwala is a Founding Radiologist of Prenuvo, a cutting edge MRI scanning technology company for early detection of cancer and other diseases.

Dr. Olla is an expert in breath technologies, breathomics, healthcare innovation, artificial and medical informatics. Dr. Olla has served as the CEO of Audacia Bioscience a health informatics company who performed substantial work in cannabis breath research and development. Dr. Olla is an associate professor at University of Detroit Mercy in Michigan and is the Vice Chair of the MedHealth Consortium.

Dr. Olla's contributions within the digital health arena have been acknowledged internationally and he has been a speaker at the United Nations conference and World Health Organization.   Notably, his professional journey includes collaborations with companies like IBM, Roche Diagnostics and Morgan Stanley. Dr. Olla holds a Ph.D. in Management Information Systems (MIS) from Brunel University, United Kingdom.

Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for several public companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Dr. Paknahad is an Electrical Engineer who has spent last 10 years on research and development and product development in biomedical and environmental monitoring devices with skills in prototyping, piloting and commercialization. Dr. Paknahad received his PhD in electrical engineering at the University of British Columbia (UBC) an completed his post-doctorate at University of Toronto. He is a specialist in the areas of microfluidics, machine olfaction, sensors, organ-on-chip and lab-on-chip technologies.